Anthonie C. Vanekris
Sits on 6 boards. Overboarded · 6 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 6
- Current seats
- 6
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 6 boards, counting each seat separately. Longest: Bancroft Fund Ltd., 2 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 28, 2026 | The Gabelli Equity Trust Inc. | Other | +500 | $5.50 | $2,750 |
| Apr 28, 2026 | The Gabelli Equity Trust Inc. | Other | +200 | $5.50 | $1,100 |
| Apr 28, 2026 | The Gabelli Equity Trust Inc. | Other | +200 | $5.50 | $1,100 |
| Feb 18, 2026 | Gabelli Dividend & Income Trust | Open-market sale | −1,700 | $29.15 | $49,555 |
| Feb 18, 2026 | GAMCO Global Gold Natural Resources & Income Trust | Open-market sale | −2,300 | $5.58 | $12,834 |
| Oct 23, 2025 | Gabelli Dividend & Income Trust | Open-market sale | −500 | $26.86 | $13,430 |
| Oct 17, 2025 | Gabelli Dividend & Income Trust | Open-market sale | −420 | $26.78 | $11,248 |
| Oct 16, 2025 | Ellsworth Growth and Income Fund Ltd. | Open-market sale | −2,000 | $12.25 | $24,500 |
| Oct 16, 2025 | Bancroft Fund Ltd. | Open-market sale | −750 | $23.53 | $17,648 |
| Oct 16, 2025 | Ellsworth Growth and Income Fund Ltd. | Open-market sale | −1,309 | $12.28 | $16,075 |
| Oct 16, 2025 | Bancroft Fund Ltd. | Open-market sale | −400 | $23.52 | $9,408 |
| Oct 14, 2025 | The Gabelli Healthcare & Wellness Trust | Open-market sale | −1,000 | $9.12 | $9,120 |
| Oct 13, 2025 | The Gabelli Healthcare & Wellness Trust | Open-market sale | −1,000 | $9.15 | $9,150 |
| Oct 9, 2025 | The Gabelli Healthcare & Wellness Trust | Open-market sale | −1,000 | $9.27 | $9,270 |
| Oct 8, 2025 | The Gabelli Healthcare & Wellness Trust | Open-market sale | −1,000 | $9.26 | $9,260 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.